Search research articles
Contact Us
Filters
Showing results (21-30 of 96) with videos related to
Page
of 10
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 20, 2022
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
Anthony Buisson, Maria Nachury, Maud Reymond, et al.
Journal of Crohn'S & Colitis
|
May 14, 2024
Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent
Mathurin Fumery, Mélanie Serrero, Guillaume Bouguen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease
Guillaume Bouguen, Audrey Huguet, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent
Anthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS study
Anthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
European Journal of Gastroenterology & Hepatology
|
July 28, 2018
Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
Gilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Digestive Diseases and Sciences
|
December 8, 2019
Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease
Eléonore Hallé, Mustapha Azahaf, Nicolas Duveau, et al.
BMC Gastroenterology
|
December 2, 2022
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
Cassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
BMC Gastroenterology
|
February 2, 2023
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
Cassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
Page
of 10
Search research articles
Search
Showing results (21-30 of 96) with videos related to
Sort By:
Page
of 10
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 20, 2022
Effectiveness of Switching From Intravenous to Subcutaneous Infliximab in Patients With Inflammatory Bowel Diseases: the REMSWITCH Study
Anthony Buisson, Maria Nachury, Maud Reymond, et al.
Journal of Crohn'S & Colitis
|
May 14, 2024
Real-World Comparison of the Effectiveness between Ustekinumab and Vedolizumab in Patients with Ulcerative Colitis Exposed to at least One Anti-TNF Agent
Mathurin Fumery, Mélanie Serrero, Guillaume Bouguen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
May 26, 2019
Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease
Guillaume Bouguen, Audrey Huguet, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics
|
November 19, 2022
Real-world comparison of effectiveness between tofacitinib and vedolizumab in patients with ulcerative colitis exposed to at least one anti-TNF agent
Anthony Buisson, Maria Nachury, Thomas Guilmoteau, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 20, 2025
Real-world comparison of the effectiveness of tofacitinib and ustekinumab in patients with ulcerative colitis: the TORUS study
Anthony Buisson, Mélanie Serrero, Romain Altwegg, et al.
European Journal of Gastroenterology & Hepatology
|
July 28, 2018
Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis
Guillaume Pineton de Chambrun, Maria Nachury, Natalie Funakoshi, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
August 31, 2019
Oral Curcumin No More Effective Than Placebo in Preventing Recurrence of Crohn's Disease After Surgery in a Randomized Controlled Trial
Gilles Bommelaer, David Laharie, Stéphane Nancey, et al.
Digestive Diseases and Sciences
|
December 8, 2019
Radiological Response Is Associated with Better Outcomes and Should Be Considered a Therapeutic Target in Crohn's Disease
Eléonore Hallé, Mustapha Azahaf, Nicolas Duveau, et al.
BMC Gastroenterology
|
December 2, 2022
Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
Cassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
BMC Gastroenterology
|
February 2, 2023
Correction: Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
Cassandra Rayer, Maria Nachury, Arnaud Bourreille, et al.
Page
of 10